β-Cell Targeted Immune Suppressive PD-1 Bispecific Agonists: A Novel Approach to Treat Type 1 Diabetes

被引：0
|
作者：
Bossi, Giovanna
Curnock, Adam P.
Weber, Peter
Kumaran, Jyothi
Bawden, Lindsay J.
Figueiredo, Rita
Wiseman, Katherine E.
O'Dwyer, Ronan
Overton, David
Gonzalez, Veronica
Lucato, Christina M. A.
Page, Keith
Smith, Nicola
Whaley, Lorraine
Ghadbane, Hemza
Knight, David
Henderson, Emma
Hearty, Stephen
Mahon, Tara
Weber, Peter
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-58-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
58-LB
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Novel cell-based bioassays for monoclonal antibody and bispecific molecules in PD-1 blockade monotherapy and combination therapy
    Grailer, Jamison
    Gilden, Julia
    Wang, Jun
    Garvin, Denise
    Stecha, Pete
    Hartnett, Jim
    Edenson, Steven
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-jie Jey
    CANCER RESEARCH, 2022, 82 (12)
  • [32] PD-1 agonist: A novel therapeutic approach to resolve atherosclerosis
    Chen, Jiahui
    Yu, Wanqian
    Liao, Le
    Fu, Linghua
    Yang, Pingping
    RESULTS IN CHEMISTRY, 2024, 12
  • [33] Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes
    Nielsen, C
    Hansen, D
    Husby, S
    Jacobsen, BB
    Lillevang, ST
    TISSUE ANTIGENS, 2003, 62 (06): : 492 - 497
  • [34] DUAL BLOCKADE OF THE PD-1 CHECKPOINT PATHWAY AND THE ADENOSINERGIC NEGATIVE FEEDBACK SIGNALING PATHWAY WITH A PD-1/CD73 BISPECIFIC ANTIBODY FOR CANCER IMMUNE THERAPY
    Zhong, Tingting
    Huang, Zhaoliang
    Pang, Xinghua
    Chen, Na
    Jin, Xiaoping
    Xia, Yu
    Wang, Zhongmin Maxwell
    Li, Baiyong
    Xia, Yu
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A422 - A422
  • [35] CDX-585, a novel bispecific antibody targeting PD-1 and ILT4
    Thomas, Lawrence J.
    Vitale, Laura A.
    Murphy, Michael
    Xia, Collin
    Peng, Zeyu
    Ejas, Asma
    Patel, Montu
    Boyer, James
    Baronas, April R.
    O'Neill, Thomas
    Widger, Jenifer
    Mills-Chen, Laura
    Crocker, Andrea
    Ma, Mark
    Chen, Mingjiu
    Davis, Hugh M.
    Hammond, Russ A.
    Taglienti, Cherie
    Yellin, Michael
    Goldstein, Joel
    Alvarado, Diego
    Marsh, Henry C.
    Keler, Tibor
    CANCER RESEARCH, 2023, 83 (07)
  • [36] RC148, a novel bispecific antibody targeting PD-1 and VEGF for cancer immunotherapy
    Fang, Jianmin
    Li, Dong
    Wu, Kaiyue
    Wang, Sisi
    Li, Du
    Zhao, Guorui
    Li, Shenjun
    Jiang, Jing
    CANCER RESEARCH, 2024, 84 (06)
  • [37] A novel bispecific c-MET/PD-1 antibody with therapeutic potential in solid cancer
    Sun, Zu-Jun
    Wu, Yi
    Hou, Wei-Hua
    Wang, Yu-Xiong
    Yuan, Qing-Yun
    Wang, Hui-Jie
    Yu, Min
    ONCOTARGET, 2017, 8 (17) : 29067 - 29079
  • [38] A novel CDH17/PD-1 bispecific antibody for treatment of advanced gastrointestinal cancers
    Wong, Kwan Wa
    Wong, Po Yee
    Chow, Kronos
    Yee, Chui O.
    Wong, Dennis
    Luk, John Moon
    Wong, Kwong Fai
    CANCER RESEARCH, 2024, 84 (06)
  • [39] A study on the efficacy and Safety Evaluation of a novel PD-1/CTLA-4 bispecific antibody
    Song, Qi
    Jiang, Meiling
    Pan, Xinrong
    Zhou, Guanyue
    Zhang, Xiaomeng
    IMMUNOBIOLOGY, 2024, 229 (06)
  • [40] Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth
    Chen, Xin
    Amar, Norhan
    Zhu, Yuankui
    Wang, Chunguang
    Xia, Chunjiao
    Yang, Xiaoqing
    Wu, Dongde
    Feng, Mingqian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
12345